Allianz’s Idexx Laboratories IDXX Stock Holding History

Allianz’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$161K	Buy	+308	New	+$169K	﹤0.01%	406

Other funds holding IDXX

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.6B AUM 22.09% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

Allianz's IDXX Position: Q3 2026 in Review

Allianz opened a new position in Idexx Laboratories (IDXX) in Q3 2026: 308 shares worth $161K. The stake represents ﹤0.01% of the portfolio and ranks #406 among its holdings.

926 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.

Allianz held 308 shares of Idexx Laboratories worth $161K as of Q3 2026.
Idexx Laboratories was a new Allianz position in Q3 2026.
Idexx Laboratories made up ﹤0.01% of Allianz's portfolio in Q3 2026, its #406 holding.
926 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.

Based on Allianz's 13F filing for Q3 2026, filed 12 Nov 2026.